Clinical Trial

Reducing High Risk Primary Tumor Clinical Target Volumes (CTVp1) in Non-metastatic Nasopharyngeal Carcinoma

Study acronym: CTVp1-NPC
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 16, 2023 (before its estimated August 4, 2026 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the long-term local control, survival rate, acute and late radiation related toxicities, quality of life after reducing high risk primary tumor clinical target volumes (CTVp1) in non-metastatic nasopharyngeal carcinoma treated with IMRT.
Trial Details
NCT Number NCT05994170
Lead Sponsor Zhongshan People's Hospital, Guangdong, China
Collaborators: Sun Yat-Sen University Cancer Center
Conditions Nasopharyngeal Carcinoma, Intensity-Modulated Radiotherapy
Enrollment 454 participants
Start Date 2023-08-04
Primary Completion 2026-08-04 (estimated)
Study Completion 2029-09-01 (estimated)
Updated on ClinicalTrials.gov 2023-08-16